Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sudeshna Ray
Institutions:
Oregon State University,
Guy's and St Thomas' NHS Foundation Trust,
EvergreenHealth,
Evergreen Health Medical Center
Observed institutions:
Oregon State University,
All India Institute of Hygiene and Public Health,
Guy's and St Thomas' NHS Foundation Trust,
EvergreenHealth,
Evergreen Health Medical Center
OpenAlex ID:
A5090548861
Depression and Anxiety in Parkinson Disease
2019
·
Sudeshna Ray
, Pinky Agarwal
·
Clinics in Geriatric Medicine
·
149
Neurological manifestations in 404 COVID-19 patients in Washington State
2020
·
Pinky Agarwal
, Sudeshna Ray
, et al.
·
Journal of Neurology
·
39
PDF
Management of lower urinary tract symptoms in Parkinson's disease in the neurology clinic
2017
·
Arina Madan
, Sudeshna Ray
, et al.
·
International Journal of Neuroscience
·
24
Altered mental status in 71 deaths due to COVID-19
2020
·
Brad Tyson
, Laszlo Erdodi
, et al.
·
International Journal of Neuroscience
·
18
A Novel Trial of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)
2022
·
Arina Madan
, Theodore Brown
, et al.
·
Cureus
·
11
PDF
Can the Availability of Unrestricted Financial Support Improve the Quality of Care of Thalassemics in a Center with Limited Resources? A Single Center Study from India
2012
·
Prantar Chakrabarti
, Vinay Kumar Bohara
, et al.
·
Thalassemia Reports
·
9
PDF
A Study on the Correlations Between Comorbid Disease Conditions and Central and Peripheral Neurological Manifestations of COVID-19
2022
·
Anya Vaish
, Sudeshna Ray
, et al.
·
Cureus
·
2
PDF
Neurological Manifestations, Comorbidities, and Outcomes of COVID-19 in Parkinson’s Disease Patients (5184)
2021
·
Uma Sharma
, Arina Madan
, et al.
·
Neurology
·
1
A Prospective, Randomized, Placebo-Controlled Pilot Study of Mirabegron (Myrbetriq®) and Behavioral Modification for Overactive Bladder in Parkinson Disease (908)
2020
·
Pinky Agarwal
, Theodore Brown
, et al.
·
Neurology
·
1
Strategizing Clinical Trial Recruitment in the Digital Age (P1.9-072)
2019
·
Pinky Agarwal
, Sudeshna Ray
, et al.
·
Neurology
·
1
Optimizing Recruitment of Racial and Ethnic minority population in Clinical Trials in Parkinson’s Disease: Potential Barriers and Prospective Strategies (P4.010)
2017
·
Pinky Agarwal
, Sudeshna Ray
, et al.
·
Neurology
·
1
Evaluation of depression, anxiety, and stress in nonmetastatic locally advanced head neck cancer patients: Prospective study in a tertiary medical center of India.
2013
·
Koustav Mazumder
, Shyamal Kumar Sarkar
, et al.
·
Journal of Clinical Oncology
·
1
Acute neurocognitive disorder as a presenting manifestation of COVID-19
2024
·
Brad Tyson
, Leigh Tyson
, et al.
·
Elsevier eBooks
Don't miss the diagnosis: neurological manifestations as presenting features of COVID-19
2023
·
Arina Madan
, Pinky Agarwal
, et al.
·
Clinical Medicine
A Report on the Association of Medical Comorbidities and Neurologic Manifestations in 484 Patients with COVID-19. (5156)
2021
·
Anya Vaish
, Brad Tyson
, et al.
·
Neurology
Efficacy and safety of ADS-5102 (amantadine) extended-release capsules for treating levodopa-induced dyskinesia
2018
·
Pinky Agarwal
, Sudeshna Ray
, et al.
·
Expert Opinion on Orphan Drugs
Clinical Research Participation: Trials And Tribulations of The Limited English Proficiency Patient Volunteer in Parkinson’s Disease Clinical Trials. (P5.071)
2018
·
Pinky Agarwal
, Sudeshna Ray
, et al.
·
Neurology
Show more works
View as search
Works count:
18
Citation count:
257
H-index:
6
I10-index:
5
Year
Topic
Type